WebMD CEO Redmond leaving; company reports narrower loss
(Reuters) - WebMD Health Corp said Chief Executive Cavan Redmond will be leaving the health information provider, less than a year after the former Pfizer Inc executive was appointed to...
All Stories
WebMD CEO Redmond leaving; company reports narrower loss
(Reuters) - WebMD Health Corp said Chief Executive Cavan Redmond will be leaving the health information provider, less than a year after the former Pfizer Inc executive was appointed to...
Arena withdraws diet drug application in Europe; shares fall
(Reuters) - Arena Pharmaceuticals Inc withdrew an application to market its anti-obesity drug in the European Union, sending its shares down 15 percent in after-hours trading. The European Medicines Agency's...
Arena withdraws diet drug application in Europe; shares fall
(Reuters) - Arena Pharmaceuticals Inc withdrew an application to market its anti-obesity drug in the European Union, sending its shares down 15 percent in after-hours trading. The European Medicines Agency's...
Vivus gets FDA nod to sell diet pill via retail pharmacies
(Reuters) - Vivus Inc President Peter Tam said U.S. health regulators' approval to sell its diet pill Qsymia through retail pharmacies removed "a major barrier" to the drug's adoption and...
Vivus gets FDA nod to sell diet pill via retail pharmacies
(Reuters) - Vivus Inc President Peter Tam said U.S. health regulators' approval to sell its diet pill Qsymia through retail pharmacies removed "a major barrier" to the drug's adoption and...
Alexza agitation drug gets EU recommendation, shares jump
(Reuters) - European health regulators recommended approval of Alexza Pharmaceuticals Inc's experimental drug Adasuve for controlling agitation in adults with schizophrenia and bipolar disorder, sending its shares up 19 percent....
Alexza agitation drug gets EU recommendation, shares jump
(Reuters) - European health regulators recommended approval of Alexza Pharmaceuticals Inc's experimental drug Adasuve for controlling agitation in adults with schizophrenia and bipolar disorder, sending its shares up 19 percent....
Sarepta’s drug helps improve walking ability, shares jump
(Reuters) - An experimental drug improved walking ability in boys suffering from a rare degenerative disease that causes progressive muscle loss, data from a new study showed, nearly tripling the...
Sarepta’s drug helps improve walking ability, shares jump
(Reuters) - An experimental drug improved walking ability in boys suffering from a rare degenerative disease that causes progressive muscle loss, data from a new study showed, nearly tripling the...